FDA expands indication for schizophrenia med; First FDA-approved injectable for double chin launches;

> The FDA allowed Otsuka's schizophrenia-fighting Abilify Maintena to be injected into the the deltoid muscle of the arm, giving it a second administration sight in addition to the gluteus. More

> Ocean Drive Plastic Surgery just launched the first FDA-approved injectable for double chin. More

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.